Altimmune Inc
ALT
Get informed when a big investor buys or sells
+ FollowMarket Cap$571.75M
Close$
$0.09
96.8% downside
Current Fair Value
96.8% downsideOvervalued by 96.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $571.75 Million |
|---|---|
| Enterprise Value | $544.45 Million |
| Dividend Yield | $1746.01 (-) |
| Earnings per Share | $-1 |
| Beta | 0.17 |
| Outstanding Shares | 185,443,736 |
Return
| Return on Equity | -19.35% |
|---|---|
| Return on Assets | -17.40% |
| Return on Invested Capital | -19.47% |
Valuation & Multiples
| P/E Ratio | -3.77 |
|---|---|
| PEG | -122.94 |
| Price to Sales | - |
| Price to Book Ratio | 1.44 |
| Enterprise Value to Revenue | 17562.89 |
| Enterprise Value to EBIT | -5.43 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$2,000
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.16
Average shareholder expectationRevenue Estimate
$1,750
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 64.29% |
|---|---|
| Total Calls | 16,500▼ 98.69% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 29.72%▼ 49.02% |
|---|---|
| Total Invested | $112.44M▼ 47.34% |
| Investors Holding | 74▼ 109.00% |
ESG Score
No data
About Altimmune Inc
CEO: Vipin Garg